PMID: 698824Oct 6, 1978Paper

Chick sympathetic neurons develop receptors for alpha-bungarotoxin in vitro, but the toxin does not block nicotinic receptors

Brain Research
E D KouvelasL A Greene


Studies were carried out on the development and physiological role of receptors for alpha-bungarotoxin (alphaBT) on chick embryo sympathetic neurons maintained in dissociated cell culture. Neurons from embryos of 13 days incubation (E13) developed alphaBT receptors in vitro with a time course and to a maximum level per cell similar to that previously observed for such neurons in vivo. In vitro receptor development by E11 and E8 neurons was also present, but (in comparison with E13 neurons) reached somewhat lower maximal levels. Receptor development in vitro was not affected by exclusion of non-neuronal cells from the cultures. In the present and in previous studies, binding of alphaBT to chick sympathetic neurons was blocked by a variety of ligands of nicotinic acetylcholine receptors. However, saturating concentrations of toxin were found here to be ineffective in blocking either (a) release of [3H]norepinephrine from the cultured neurons elicited via nicotinic stimulation of acetylcholine receptors or (b) depolarizing responses of the cultured neurons elicited by iontophoretically applied acetylcholine and nicotine. Kinetic studies further revealed that, while the idssociation of alphaBT from the cultured neurons is considera...Continue Reading


Nov 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·E J FurshpanD D Potter
Jun 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·Z Vogel, M Nirenberg
Jan 1, 1972·Annual Review of Pharmacology·C Y Lee
Sep 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·P H O'LagueD D Potter
Sep 5, 1974·Biochimica Et Biophysica Acta·V A Eterović, E L Bennett
Jan 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·A J SytkowskiM Nirenberg
Nov 1, 1973·The Journal of Cell Biology·R E Mains, P H Patterson


Aug 18, 1980·Life Sciences·R E Oswald, J A Freeman
Jan 1, 1982·Pharmacology & Therapeutics·A T EldefrawiM E Eldefrawi
Feb 1, 1988·Trends in Neurosciences·R H Loring, R E Zigmond
Apr 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·P M Ravdin, D K Berg
Mar 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·L M Marshall
Feb 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·R I NormanJ O Dolly
Nov 25, 1998·Proceedings of the National Academy of Sciences of the United States of America·M G LópezA G García
Jul 1, 1984·Journal of Neurochemistry·M R Whipple, D G Drescher
Dec 1, 1981·Journal of Neurochemistry·R E Oswald, J A Freeman
Jan 1, 1981·Annals of the New York Academy of Sciences·K PeperR J Bradley
Jan 1, 1987·Molecular Neurobiology·J LindstromP Whiting
Jun 1, 1981·British Journal of Pharmacology·B CollierP A Smith
Jun 1, 1981·European Journal of Biochemistry·H Betz

Related Concepts

Acetylcholine Sulfate (1: 1)
Adrenergic Fibers
Chick Embryo
Autonomic Ganglion
Resting Potentials
Norepinephrine, (+, -)-Isomer
Cholinergic Receptors
Nicotinic Receptors

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Generating Insulin-Secreting Cells

Reprogramming cells or using induced pluripotent stem cells to generate insulin-secreting cells has significant therapeutic implications for diabetics. Here is the latest research on generation of insulin-secreting cells.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Epigenome Editing

Epigenome editing is the directed modification of epigenetic marks on chromatin at specified loci. This tool has many applications in research as well as in the clinic. Find the latest research on epigenome editing here.